Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2005
10/25/2005US6958339 Pyrazole derivative
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005CA2332461C New benzenesulfonamide derivatives, their method of preparation and the pharmaceutical compositions containing them
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/20/2005WO2005097791A1 Inhibitors of iap
10/20/2005WO2005097787A2 Novel benzothiazoles and the use thereof as medicaments
10/20/2005WO2005097786A1 Oxadiazolone derivatives as ppar delta agonists
10/20/2005WO2005097784A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005WO2005097782A1 Piperidine derivative
10/20/2005WO2005097776A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
10/20/2005WO2005097774A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/20/2005WO2005097767A1 2-aminothiazole compounds useful as aspartyl protease inhibitors
10/20/2005WO2005097766A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
10/20/2005WO2005097765A1 Anaplastic lymphoma kinase modulators and methods of use
10/20/2005WO2005097764A1 Thiazole derivative
10/20/2005WO2005097763A2 1,3,4-oxadiazol-2-ones as ppar delta
10/20/2005WO2005097762A2 1,3,4-oxadiazol-2-ones as ppar delta modulators
10/20/2005WO2005097758A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005WO2005097750A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005097137A2 Advanced quinazoline based protein kinase inhibitors
10/20/2005WO2005097136A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005WO2005097134A2 Quinazoline based protein kinase inhibitors
10/20/2005WO2005097117A1 Thiadiazolidinones as gsk-3 inhibitors
10/20/2005WO2005097116A1 Composition comprising a jnk inhibitor and cyclosporin
10/20/2005WO2005097114A2 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
10/20/2005WO2005097112A2 Ion channel modulators
10/20/2005WO2005085236A3 Caspase inhibitors and uses thereof
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005051931A3 Phosphodiesterase inhibitors
10/20/2005WO2004071460A3 Cyclic derivatives as modulators of chemokine receptor activity
10/20/2005WO2003106413A3 Process for the preparation of oxazolidinones and method of use thereof
10/20/2005US20050234247 New effector conjugates, process for their production and their pharmaceutical use
10/20/2005US20050234242 Coupling of a 2-haloindole with an (hetero)aryl zinc intermediate in the presence of a palladium or nickel-containing catalyst, phosphine ligand and a solvent selected from tetrahydrofuran, dimethylformamide and N-methylpyrrolidone; by-product inhibition; hepatitis C virus polymerase inhibitors
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234098 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234080 Mitotic kinesin inhibitors
10/20/2005US20050234079 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy] benzyl]thiazolidine-2,4-dione potassium salt
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234064 2-(4-Methoxyphenyl)-amino-),3-(aminocarbonyl-)quinoxaline; janus(JAK) kinase inhibitors;spleen tyrosine kinase(SYK) inhibitors; glycogen synthase-3(GSK-3) kinase inhibitors; immunocompetance; antiinflammatory agents; antiallergens; autoimmune diseases; antiproliferative agents; respiratory disorders
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234059 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
10/20/2005US20050234057 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof
10/20/2005US20050234055 Pyrazole derivative
10/20/2005US20050234049 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234047 Respiratory syncytial virus replication inhibitors
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050234045 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005US20050234042 Organic compounds
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234038 Protease inhibitors
10/20/2005US20050234033 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine;antiprolifrative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype;
10/20/2005US20050234030 Modulators of CRTH2, COX-2 and FAAH
10/20/2005US20050234020 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
10/20/2005US20050233979 Use in controlling apoptosis, as antiinflammatory agents, in treating autoimmune disease, as antiischemic agents, in treating cardiovascular disorders; for example, (S,S)-3-[2-(3-Acetylamino-2-oxo-2H-pyridin-1-yl)-butyrylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid
10/20/2005US20050233909 such as 6-(5-chlorobenzoxazol-2-yl)-2-(3-trifluoromethylphenoxy)pyridine, used on monocotyledonus or dicotyledonus weeds
10/20/2005CA2562780A1 Nucleic acid melting analysis with saturation dyes
10/20/2005CA2562140A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005CA2561967A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/20/2005CA2561928A1 Thiazole sulfonamide compounds for the treatment of neurodegenerative disorders
10/20/2005CA2561907A1 Composition comprising a jnk inhibitor and cyclosporin
10/20/2005CA2561738A1 1,3,4-oxadiazol-2-ones as ppar delta modulators_and their use thereof
10/20/2005CA2561627A1 Oxadiazolone derivatives as ppar delta agonists
10/20/2005CA2561280A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005CA2561267A1 2-aminothiazole compounds useful as aspartyl protease inhibitors
10/20/2005CA2561249A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
10/20/2005CA2561230A1 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
10/20/2005CA2560954A1 Certain triazole-based compounds, compositions, and uses thereof
10/20/2005CA2560796A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005CA2560683A1 Novel benzothiazoles and the use thereof as medicaments
10/20/2005CA2560162A1 Inhibitors of iap
10/20/2005CA2559866A1 Anaplastic lymphoma kinase modulators and methods of use
10/20/2005CA2559740A1 Thiadiazolidinones as gsk-3 inhibitors
10/20/2005CA2557721A1 Ion channel modulators
10/19/2005EP1586573A1 Oxadiazolones, processes for their preparation and their use as pharmaceuticals
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586565A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1586319A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1586318A1 Thiadiazolidinones as GSK-3 inhibitors
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585739A1 Substituted arylcyclopropylacetamides as glucokinase activators
10/19/2005EP1585737A2 Uracils having a herbicidal activity
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585728A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
10/19/2005EP1585727A1 Indoles useful in the treatment of androgen-receptor related diseases
10/19/2005EP1585726A1 Fused heterocyclic derivatives as ppar modulators
10/19/2005EP1585725A2 Compounds which mimic the chemical and biological properties of discodermolide
10/19/2005EP1585720A1 Process for converting a cis-trans mixture of substituted benzylidene amines into the pure cis isomer
10/19/2005EP1585541A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 628